PT-141 Pen

PT‑141, also known as Bremelanotide, is a synthetic peptide from the melanocortin family. Unlike traditional sexual enhancement approaches that act on the vascular system, PT‑141 works directly on the central nervous system to influence pathways involved in sexual desire and arousal. This mechanism makes it a unique candidate in research focused on libido and intimacy support.

⚗️ Product Features

• 🧪 Melanocortin receptor agonist peptide

• 🧠 Targets central nervous system pathways related to desire

• ✅ ≥98 % purity verified by HPLC

• 📄 Batch‑specific Certificates of Analysis (COAs) included

• 💧 Sterile, lyophilized peptide for research applications

🔬 Human‑Relevant Research Applications

🔥 Enhances Sexual Desire & Arousal

Clinical Phase III trials have demonstrated that bremelanotide significantly improves sexual desire scores and reduces distress associated with low sexual desire in premenopausal women with hypoactive sexual desire disorder (HSDD) compared with placebo, based on validated measures such as the Female Sexual Function Index (FSFI) desire domain.

🔗 https://pubmed.ncbi.nlm.nih.gov/31599840/— Bremelanotide increases sexual desire and reduces distress in HSDD Phase III trials.

🧾 Mechanism Summary

• 🧠 Central melanocortin receptor (MC4R) agonism influences neural circuits of desire and arousal

• 📈 Clinically linked to increased desire scores in validated human trials

• 🧩 Distinct mechanism from vascular‑targeted sexual enhancement agents

❓ Frequently Asked Research Questions

What has PT‑141 been studied for in humans?
PT‑141 has been studied mainly for enhancing sexual desire and reducing distress related to low sexual desire in premenopausal women with hypoactive sexual desire disorder, with statistically significant results in clinical Phase III trials.